NCT03445624View on ClinicalTrials.gov

Abdominal Ultrasound With Doppler and Peripheral Hemogram in Assesment Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

February 1, 2021

Study Completion Date

October 1, 2021

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

Infliximab

follow up the patients who received this drugs for 1 year by abdominal ultrasound,peripheral hemogram and colonoscopy

Trial Locations (1)

Unknown

Hyam Fathy, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03445624 - Abdominal Ultrasound With Doppler and Peripheral Hemogram in Assesment Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter